ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.924,19
-1,12%
S&P 500
5.018,39
-0,34%
US Dollar vs BRL
5,1958
0,00%
Bitcoin
57.479,43
-1,30%
Brent Oil
83,845
0,37%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. ResMed Inc (RMD)

  7. ResMed Inc (RMD) Notícias

RMD

ResMed (RMD)

ResMed Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:RMD
DataHoraFonteTítuloCódigoCompanhia
25/04/202417:05GlobeNewswire Inc.ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024NYSE:RMDResMed Inc
04/04/202417:05GlobeNewswire Inc.ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024NYSE:RMDResMed Inc
15/03/202404:05GlobeNewswire Inc.ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep CrisisNYSE:RMDResMed Inc
06/03/202422:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RMDResMed Inc
06/03/202411:05GlobeNewswire Inc.Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP MaskNYSE:RMDResMed Inc
04/03/202419:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RMDResMed Inc
12/02/202418:16GlobeNewswire Inc.ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep ApneaNYSE:RMDResMed Inc
07/02/202410:05GlobeNewswire Inc.MatrixCare Earns Three 2024 Best in KLAS AwardsNYSE:RMDResMed Inc
29/01/202408:09IH Market NewsPhilips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and latest newsNYSE:RMDResMed Inc
29/01/202408:09IH Market NewsPhilips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and more Wall Street HighlightsNYSE:RMDResMed Inc
25/01/202415:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:RMDResMed Inc
24/01/202418:06Edgar (US Regulatory)Form 8-K - Current reportNYSE:RMDResMed Inc
24/01/202418:05GlobeNewswire Inc.ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024NYSE:RMDResMed Inc
03/01/202418:05GlobeNewswire Inc.ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024NYSE:RMDResMed Inc
27/12/202318:05GlobeNewswire Inc.ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:RMDResMed Inc
20/12/202318:05GlobeNewswire Inc.ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical DevicesNYSE:RMDResMed Inc
11/12/202318:05GlobeNewswire Inc.ResMed Secures Significant Victory in Patent Fight Against New York UniversityNYSE:RMDResMed Inc
07/12/202317:34GlobeNewswire Inc.Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients GloballyNYSE:RMDResMed Inc
21/11/202318:36Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:RMDResMed Inc
09/11/202318:05GlobeNewswire Inc.ResMed Adopts New Operating Model to Accelerate Long-term GrowthNYSE:RMDResMed Inc
26/10/202317:05GlobeNewswire Inc.ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024NYSE:RMDResMed Inc
13/10/202318:00Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNYSE:RMDResMed Inc
10/10/202308:02IH Market NewsKeep An Eye Out: Pre-Market Movers And RecommendationsNYSE:RMDResMed Inc
05/10/202317:05GlobeNewswire Inc.ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023NYSE:RMDResMed Inc
05/10/202315:48Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNYSE:RMDResMed Inc
05/10/202315:45Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:RMDResMed Inc
05/10/202315:43Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNYSE:RMDResMed Inc
05/09/202317:05GlobeNewswire Inc.ResMed Announces Participation in Upcoming ConferencesNYSE:RMDResMed Inc
03/08/202317:05GlobeNewswire Inc.ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023NYSE:RMDResMed Inc
06/07/202318:00Business WireRichmond Minerals Inc. Announces the Final Sale of Lithium Exploration Licenses in AustriaNYSE:RMDResMed Inc
 Apresentando as notícias mais relevantes sobre:NYSE:RMD

Seu Histórico Recente

BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
SGPS3
SPRINGS ON
BOV
RSID3
ROSSI RESID ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados